Production (Stage)
SBC Medical Group Holdings Incorporated
SBC
$4.55
$0.7118.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.65% | 6.13% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.65% | 6.13% | -- | -- | -- |
| Cost of Revenue | -23.56% | -12.22% | -- | -- | -- |
| Gross Profit | 4.02% | 13.65% | -- | -- | -- |
| SG&A Expenses | -1.07% | -3.44% | -- | -- | -- |
| Depreciation & Amortization | -52.37% | -- | -- | -- | -- |
| Other Operating Expenses | 150.78% | 133.73% | -- | -- | -- |
| Total Operating Expenses | -7.05% | -2.30% | -- | -- | -- |
| Operating Income | 1.26% | 20.81% | -- | -- | -- |
| Income Before Tax | -12.20% | -0.17% | -- | -- | -- |
| Income Tax Expenses | -24.83% | -23.57% | -- | -- | -- |
| Earnings from Continuing Operations | -2.87% | 21.08% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -105.90% | -109.35% | -- | -- | -- |
| Net Income | -5.31% | 18.40% | -- | -- | -- |
| EBIT | 1.26% | 20.81% | -- | -- | -- |
| EBITDA | -6.35% | 7.54% | -- | -- | -- |
| EPS Basic | 47.39% | 65.35% | -- | -- | -- |
| Normalized Basic EPS | 28.58% | 40.22% | -- | -- | -- |
| EPS Diluted | 50.82% | 69.21% | -- | -- | -- |
| Normalized Diluted EPS | 28.58% | 40.22% | -- | -- | -- |
| Average Basic Shares Outstanding | 6.39% | 52.80% | -- | -- | -- |
| Average Diluted Shares Outstanding | 6.39% | 52.80% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |